NCT03360656View on ClinicalTrials.gov

Transnasal Induction of Normothermia in Febrile Stroke Patients

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

January 16, 2018

Primary Completion Date

April 22, 2022

Study Completion Date

April 22, 2022

Conditions
Stroke, IschemicStroke HemorrhagicFeverSeizuresMetabolic Encephalopathy
Interventions
DEVICE

Transnasal Thermal Regulating Device

Placement of transnasal thermal regulating device to reduce temperature in febrile patients for a period of 8 to 24 hours

Trial Locations (3)

20010

MedStar Washington Hospital Center, Washington D.C.

21201

University of Maryland Medical Center, Baltimore

77030

University of Texas, Houston, Houston

All Listed Sponsors
lead

CoolTech LLC

INDUSTRY

NCT03360656 - Transnasal Induction of Normothermia in Febrile Stroke Patients | Biotech Hunter | Biotech Hunter